A Phase II Open Label Multicenter Study of PSMA ADC in Subjects with Castration-resistant Metastatic Prostate Cancer

Diseases and Conditions Researched

Cancer; Prostate

What is the purpose of this trial?

The objective of PSMA ADC 2301 in subjects with progressive, CRMPC is to assess the anti-tumor activity and tolerability of PSMA ADC.

Participation Guidelines

Age: 18 Years and older
Gender: Male

Click here for detailed participation information for this trial.

Sponsor: PSMA Development Company LLC
Last Updated:
Study HIC#: 1211011046